{"id":"https://openalex.org/W97615409","doi":null,"title":"[A case of bleeding tendency due to warfarin in a patient treated with chemotherapy by S-1].","display_name":"[A case of bleeding tendency due to warfarin in a patient treated with chemotherapy by S-1].","alternate_titles":[],"publication_year":2008,"publication_date":"2008-08-01","ids":{"openalex":"https://openalex.org/W97615409","mag":"97615409","pmid":"https://pubmed.ncbi.nlm.nih.gov/18701850"},"language":"ja","primary_location":{"id":"pmid:18701850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18701850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},"parent_works":[],"lineage":["https://openalex.org/W97615409"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110348807","display_name":"Yukako Yasui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104391","display_name":"Sakai City Medical Center","ror":"https://ror.org/014nm9q97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210104391","https://openalex.org/I4405286217"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukako Yasui","raw_affiliation_strings":["Dept. of Pharmacy, Sakai Municipal Hospital, Graduate School of Pharmaceutical Sciences, Osaka University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Pharmacy, Sakai Municipal Hospital, Graduate School of Pharmaceutical Sciences, Osaka University","institution_ids":["https://openalex.org/I4210104391","https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054553533","display_name":"Tomoko Nishiguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomoko Nishiguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000336663","display_name":"Akinori Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akinori Yamamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034435379","display_name":"Chika Fujii","orcid":"https://orcid.org/0000-0002-7494-5424","observed_orcids":["https://orcid.org/0000-0002-7494-5424"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chika Fujii","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074919277","display_name":"Misako Fujino","orcid":"https://orcid.org/0000-0003-2115-7958","observed_orcids":["https://orcid.org/0000-0003-2115-7958"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Misako Fujino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001673396","display_name":"\u9ebb\u7d00\u5b50 \u67d8\u690d","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Makiko Tsuge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111440183","display_name":"Masako Ohno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masako Ohno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Junichi Azuma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Junichi Azuma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111587195","display_name":"Tae Matsumura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tae Matsumura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103501248","display_name":"Hiroki Ohsato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroki Ohsato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062737273","display_name":"Setsuko Anami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Setsuko Anami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057163448","display_name":"Hiroshi Furukawa","orcid":"https://orcid.org/0000-0003-1353-8056","observed_orcids":["https://orcid.org/0000-0003-1353-8056"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Furukawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3803,"has_fulltext":false,"cited_by_count":4,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.57831165,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"35","issue":"8","first_page":"1367","last_page":"1370"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8759999871253967},{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hemorrhagic-diathesis","display_name":"bleeding tendency","score":0.7200000286102295},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.7689999938011169},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.6710000038146973},{"id":"https://openalex.org/keywords/vkorc1","display_name":"VKORC1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6179999709129333},{"id":"https://openalex.org/keywords/anticoagulation-monitoring","display_name":"anticoagulation monitoring","score":0.6259999871253967},{"id":"https://openalex.org/keywords/international-normalized-ratio","display_name":"international normalized ratio","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":0.8220000267028809},{"id":"https://openalex.org/keywords/internal-jugular-vein-thrombosis","display_name":"internal jugular vein thrombosis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.7110000252723694},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8266308307647705},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6287647485733032},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.589246928691864},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.47102436423301697},{"id":"https://openalex.org/C2776259030","wikidata":"https://www.wikidata.org/wiki/Q769508","display_name":"Bleed","level":2,"score":0.4644933044910431},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43169838190078735},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.42999422550201416},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4056062400341034},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38488078117370605},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38149023056030273},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.08935171365737915},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004379","descriptor_name":"Duodenal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004379","descriptor_name":"Duodenal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18701850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18701850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},{"id":"mag:97615409","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18701850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2622807458","https://openalex.org/W2016868838","https://openalex.org/W7221794951","https://openalex.org/W2553793540","https://openalex.org/W2009816494","https://openalex.org/W2245317973","https://openalex.org/W125791150","https://openalex.org/W2411153694","https://openalex.org/W2046589790","https://openalex.org/W2336611866"],"abstract_inverted_index":{"A":[0],"82-year-old":[1],"male":[2],"patient":[3,229,265],"had":[4,156],"suffered":[5],"from":[6,196],"a":[7,73,153,157,228,231,236,240],"cancer":[8],"of":[9,12,21,27,58,72,79,113,128,142,152,163,169,187,211,221,227,245,255,264],"the":[10,15,30,36,51,68,87,97,101,111,118,131,150,184,197,219,225],"papilla":[11],"Vater.":[13],"After":[14],"operation,":[16],"he":[17,202],"received":[18],"4":[19],"courses":[20],"gemcitabine(GEM)adjuvant":[22],"chemotherapy":[23,43,52],"and":[24,42,46,64,110,173,208,260],"warfarin(WF)administration":[25],"because":[26,57],"thrombosis":[28],"in":[29,60,67,137,167,239,249],"left":[31],"internal":[32],"jugular":[33],"vein.":[34],"Since":[35,130],"tumors":[37],"re-grew,":[38],"GEM":[39,47],"was":[40,48,84,94,123,144,235],"discontinued,":[41],"including":[44],"S-1":[45,259],"examined.":[49],"However,":[50],"could":[53],"not":[54,217],"be":[55],"continued":[56],"edema":[59],"both":[61],"lower":[62],"legs":[63],"tassel":[65],"midway":[66],"2nd":[69],"course.":[70],"Because":[71,224],"bleeding":[74],"tendency(non-measurable":[75],"INR(international":[76],"normalized":[77],"ratio":[78],"prothrombin":[80],"time)),":[81],"WF":[82,143,164,261],"administration":[83],"discontinued":[85],"on":[86,117],"11th":[88],"day":[89],"after":[90,135,192],"S-1/GEM":[91],"combined":[92],"therapy":[93],"suspended.":[95],"On":[96],"following":[98],"day,":[99],"although":[100],"INR":[102,122,132,246],"value":[103],"recovered":[104],"to":[105,139,148,159,233,251],"1.7,":[106],"it":[107],"gradually":[108],"worsened":[109],"symptoms":[112],"pulmonary":[114],"embolism":[115],"developed":[116],"13th":[119],"day.":[120],"Then,":[121],"controlled":[124],"by":[125,161,190,258],"continuous":[126],"infusion":[127],"heparin.":[129],"level":[133],"decreased":[134],"that,":[136],"addition":[138],"heparin,":[140],"re-medication":[141],"performed.":[145],"We":[146,181,199],"tried":[147],"analyze":[149],"genotype":[151,226],"patient,":[154],"who":[155],"tendency":[158,232],"bleed":[160,234],"coadministration":[162],"with":[165,230],"S-1,":[166],"terms":[168],"hepatic":[170],"cytochrome":[171],"P-450(CYP)2C9":[172],"vitamin":[174],"K":[175],"epoxide":[176],"reductase":[177],"complex":[178],"subunit":[179],"1(VKORC1).":[180],"also":[182],"measured":[183],"plasma":[185],"concentration":[186],"S-and":[188],"R-WF":[189],"HPLC":[191],"obtaining":[193],"informed":[194],"consent":[195],"patient.":[198],"found":[200],"that":[201],"is":[203,247],"homozygous":[204],"for":[205,209],"CYP2C9":[206],"1/1":[207],"A/A":[210],"VKORC1(-1639G>A).":[212],"The":[213],"obtained":[214],"data":[215],"did":[216],"show":[218],"abnormalities":[220],"blood":[222,256],"coagulation.":[223],"major":[237],"type":[238],"Japanese":[241],"population,":[242],"fine":[243],"monitoring":[244],"required":[248],"order":[250],"prevent":[252],"side":[253],"effects":[254],"coagulation":[257],"coadministration,":[262],"regardless":[263],"genotypes.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W97615409","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
